Nu Skin Enterprises (NUS) Stock Forecast, Price Target & Predictions
NUS Stock Forecast
Nu Skin Enterprises stock forecast is as follows: an average price target of $11.00 (represents a 66.67% upside from NUS’s last price of $6.60) and a rating consensus of 'Strong Buy', based on 0 wall street analysts offering a 1-year stock forecast.
NUS Price Target
The average price target for Nu Skin Enterprises (NUS) is $11.00 based on 1-year price targets from 0 Wall Street analysts in the past 3 months, with a price target range of $11.00 to $11.00. This represents a potential 66.67% upside from NUS's last price of $6.60.
NUS Analyst Ratings
According to 0 Wall Street analysts, Nu Skin Enterprises's rating consensus is 'Strong Buy'. The analyst rating breakdown for NUS stock is 0 'Strong Buy' (NaN%), 0 'Buy' (NaN%), 0 'Hold' (NaN%), 0 'Sell' (NaN%), and 0 'Strong Sell' (NaN%).
Nu Skin Enterprises Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 12, 2024 | Linda Bolton Weiser | D.A. Davidson | $11.00 | $9.21 | 19.37% | 66.67% |
| Nov 23, 2022 | D.A. Davidson | $34.00 | $39.36 | -13.62% | 415.15% |
The latest Nu Skin Enterprises stock forecast, released on Aug 12, 2024 by Linda Bolton Weiser from D.A. Davidson, set a price target of $11.00, which represents a 19.37% increase from the stock price at the time of the forecast ($9.21), and a 66.67% increase from NUS last price ($6.60).
Nu Skin Enterprises Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 1 |
| Avg Price Target | - | - | $11.00 |
| Last Closing Price | $6.60 | $6.60 | $6.60 |
| Upside/Downside | -100.00% | -100.00% | 66.67% |
In the current month, the average price target of Nu Skin Enterprises stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Nu Skin Enterprises's last price of $6.60. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 20, 2024 | Zacks Investment Research | Cautious | Cautious | Hold |
| Oct 23, 2023 | Cowen & Co. | Underperform | Underperform | Hold |
Nu Skin Enterprises's last stock rating was published by Zacks Investment Research on Aug 20, 2024. The company gave NUS a "Cautious" rating, the same as its previous rate.
Nu Skin Enterprises Financial Forecast
Nu Skin Enterprises Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | $488.64M | $498.77M | $500.26M | $481.46M | $522.34M | $537.80M | $560.62M | $604.90M | $673.44M | $641.15M | $704.05M | $677.03M | $748.19M | $703.35M | $612.37M | $518.03M | $583.36M | $589.93M | $623.50M | $623.62M | $616.22M | $499.10M |
| Avg Forecast | $451.50M | $440.98M | $440.13M | $412.04M | $435.24M | $440.97M | $431.87M | $426.55M | $476.39M | $520.09M | $509.30M | $477.49M | $542.32M | $569.82M | $574.11M | $579.69M | $655.93M | $639.89M | $702.54M | $635.40M | $749.73M | $689.59M | $583.93M | $480.84M | $582.08M | $606.27M | $622.42M | $615.84M | $664.34M | $489.31M |
| High Forecast | $460.87M | $450.14M | $449.27M | $420.60M | $444.27M | $441.16M | $431.87M | $426.55M | $478.63M | $529.07M | $519.87M | $487.41M | $553.58M | $569.82M | $574.11M | $579.69M | $655.93M | $639.89M | $702.54M | $635.40M | $749.73M | $689.59M | $583.93M | $480.84M | $582.08M | $606.27M | $622.42M | $615.84M | $797.21M | $587.18M |
| Low Forecast | $441.10M | $430.83M | $430.00M | $402.56M | $425.22M | $440.78M | $431.87M | $426.55M | $474.14M | $509.99M | $497.57M | $466.50M | $529.84M | $569.82M | $574.11M | $579.69M | $655.93M | $639.89M | $702.54M | $635.40M | $749.73M | $689.59M | $583.93M | $480.84M | $582.08M | $606.27M | $622.42M | $615.84M | $531.47M | $391.45M |
| # Analysts | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 16 | 8 | 11 | 7 | 11 | 7 | 7 | 17 | 8 |
| Surprise % | - | - | - | - | - | - | - | - | 1.03% | 0.96% | 0.98% | 1.01% | 0.96% | 0.94% | 0.98% | 1.04% | 1.03% | 1.00% | 1.00% | 1.07% | 1.00% | 1.02% | 1.05% | 1.08% | 1.00% | 0.97% | 1.00% | 1.01% | 0.93% | 1.02% |
Nu Skin Enterprises's average Quarter revenue forecast for Mar 24 based on 1 analysts is $426.55M, with a low forecast of $426.55M, and a high forecast of $426.55M. NUS's average Quarter revenue forecast represents a -12.71% decrease compared to the company's last Quarter revenue of $488.64M (Dec 23).
Nu Skin Enterprises EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 16 | 8 | 11 | 7 | 11 | 7 | 7 | 17 | 8 |
| EBITDA | - | - | - | - | - | - | - | - | $-28.89M | $-26.36M | $42.51M | $35.64M | $64.20M | $39.96M | $70.16M | $69.28M | $36.90M | $88.10M | $100.94M | $82.84M | $110.14M | $92.67M | $77.92M | $49.49M | $72.26M | $84.22M | $89.93M | $85.41M | $79.10M | $59.32M |
| Avg Forecast | $49.64M | $48.48M | $48.39M | $45.30M | $47.85M | $48.48M | $47.48M | $77.51M | $52.37M | $57.18M | $55.99M | $70.46M | $33.75M | $60.11M | $60.57M | $64.05M | $69.20M | $67.51M | $74.12M | $60.98M | $79.09M | $72.75M | $61.60M | $30.48M | $61.41M | $63.96M | $65.66M | $79.48M | $84.84M | $58.13M |
| High Forecast | $50.67M | $49.49M | $49.39M | $46.24M | $48.84M | $48.50M | $47.48M | $93.01M | $52.62M | $58.16M | $57.15M | $84.55M | $40.50M | $60.11M | $60.57M | $76.86M | $69.20M | $67.51M | $74.12M | $73.17M | $79.09M | $72.75M | $61.60M | $36.58M | $61.41M | $63.96M | $65.66M | $95.38M | $101.80M | $69.76M |
| Low Forecast | $48.49M | $47.36M | $47.27M | $44.25M | $46.75M | $48.46M | $47.48M | $62.00M | $52.12M | $56.07M | $54.70M | $56.37M | $27.00M | $60.11M | $60.57M | $51.24M | $69.20M | $67.51M | $74.12M | $48.78M | $79.09M | $72.75M | $61.60M | $24.39M | $61.41M | $63.96M | $65.66M | $63.58M | $67.87M | $46.51M |
| Surprise % | - | - | - | - | - | - | - | - | -0.55% | -0.46% | 0.76% | 0.51% | 1.90% | 0.66% | 1.16% | 1.08% | 0.53% | 1.31% | 1.36% | 1.36% | 1.39% | 1.27% | 1.26% | 1.62% | 1.18% | 1.32% | 1.37% | 1.07% | 0.93% | 1.02% |
3 analysts predict NUS's average Quarter EBITDA for Sep 23 to be $57.18M, with a high of $58.16M and a low of $56.07M. This is 34.51% upper than Nu Skin Enterprises's previous annual EBITDA (Jun 23) of $42.51M.
Nu Skin Enterprises Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 16 | 8 | 11 | 7 | 11 | 7 | 7 | 17 | 8 |
| Net Income | - | - | - | - | - | - | - | - | $7.28M | $-36.95M | $26.89M | $11.38M | $57.22M | $-25.39M | $34.24M | $38.72M | $-9.23M | $49.73M | $59.34M | $47.43M | $73.47M | $56.31M | $41.85M | $19.73M | $40.11M | $44.09M | $46.35M | $43.00M | $35.54M | $27.49M |
| Avg Forecast | $4.97M | $13.37M | $16.52M | $9.89M | $11.23M | $9.78M | $8.32M | $44.24M | $-1.24M | $31.99M | $26.52M | $40.22M | $-8.44M | $18.38M | $39.04M | $36.57M | $47.09M | $42.61M | $52.07M | $34.91M | $59.09M | $49.72M | $30.01M | $12.15M | $35.69M | $37.69M | $41.08M | $40.02M | $38.11M | $26.94M |
| High Forecast | $5.11M | $13.74M | $16.96M | $10.16M | $11.53M | $9.91M | $8.32M | $53.09M | $-1.02M | $35.61M | $27.24M | $48.27M | $-6.76M | $18.38M | $39.04M | $43.88M | $47.09M | $42.61M | $52.99M | $41.90M | $59.09M | $49.72M | $30.01M | $14.58M | $35.69M | $37.69M | $41.08M | $48.02M | $45.74M | $32.33M |
| Low Forecast | $4.82M | $12.97M | $16.02M | $9.60M | $10.89M | $9.64M | $8.31M | $35.40M | $-1.47M | $29.41M | $25.73M | $32.18M | $-10.13M | $18.38M | $39.04M | $29.25M | $47.09M | $42.61M | $51.16M | $27.93M | $59.09M | $49.72M | $30.01M | $9.72M | $35.69M | $37.69M | $41.08M | $32.01M | $30.49M | $21.55M |
| Surprise % | - | - | - | - | - | - | - | - | -5.86% | -1.16% | 1.01% | 0.28% | -6.78% | -1.38% | 0.88% | 1.06% | -0.20% | 1.17% | 1.14% | 1.36% | 1.24% | 1.13% | 1.39% | 1.62% | 1.12% | 1.17% | 1.13% | 1.07% | 0.93% | 1.02% |
Nu Skin Enterprises's average Quarter net income forecast for Mar 24 is $44.24M, with a range of $35.40M to $53.09M. NUS's average Quarter net income forecast represents a 507.58% increase compared to the company's last Quarter net income of $7.28M (Dec 23).
Nu Skin Enterprises SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 16 | 8 | 11 | 7 | 11 | 7 | 7 | 17 | 8 |
| SG&A | - | - | - | - | - | - | - | - | $326.36M | $318.63M | $322.21M | $322.02M | $328.69M | $354.46M | $360.99M | $391.25M | $427.47M | $416.86M | $446.70M | $443.55M | $464.75M | $445.75M | $400.18M | $355.67M | $388.11M | $379.88M | $395.27M | $408.31M | $410.95M | $341.57M |
| Avg Forecast | $292.37M | $285.56M | $285.01M | $266.82M | $281.84M | $285.55M | $279.66M | $276.22M | $308.49M | $336.79M | $329.80M | $406.47M | $391.02M | $367.68M | $370.45M | $369.52M | $423.25M | $412.90M | $453.33M | $326.50M | $483.77M | $444.97M | $376.79M | $219.09M | $375.59M | $391.20M | $401.63M | $379.95M | $440.73M | $334.74M |
| High Forecast | $298.44M | $291.49M | $290.93M | $272.36M | $287.69M | $285.68M | $279.66M | $276.22M | $309.94M | $342.61M | $336.65M | $487.76M | $469.23M | $367.68M | $370.45M | $443.42M | $423.25M | $412.90M | $453.33M | $391.80M | $483.77M | $444.97M | $376.79M | $262.91M | $375.59M | $391.20M | $401.63M | $455.94M | $528.87M | $401.69M |
| Low Forecast | $285.64M | $278.99M | $278.45M | $260.68M | $275.35M | $285.43M | $279.66M | $276.21M | $307.04M | $330.25M | $322.21M | $325.18M | $312.82M | $367.68M | $370.45M | $295.61M | $423.25M | $412.90M | $453.33M | $261.20M | $483.77M | $444.97M | $376.79M | $175.27M | $375.59M | $391.20M | $401.63M | $303.96M | $352.58M | $267.79M |
| Surprise % | - | - | - | - | - | - | - | - | 1.06% | 0.95% | 0.98% | 0.79% | 0.84% | 0.96% | 0.97% | 1.06% | 1.01% | 1.01% | 0.99% | 1.36% | 0.96% | 1.00% | 1.06% | 1.62% | 1.03% | 0.97% | 0.98% | 1.07% | 0.93% | 1.02% |
Nu Skin Enterprises's average Quarter SG&A projection for Mar 24 is $276.22M, based on 1 Wall Street analysts, with a range of $276.21M to $276.22M. The forecast indicates a -15.36% fall compared to NUS last annual SG&A of $326.36M (Dec 23).
Nu Skin Enterprises EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 16 | 8 | 11 | 7 | 11 | 7 | 7 | 17 | 8 |
| EPS | - | - | - | - | - | - | - | - | $0.15 | $-0.74 | $0.54 | $0.23 | $1.16 | $-0.51 | $0.68 | $0.77 | $-0.19 | $0.99 | $1.18 | $0.94 | $1.43 | $1.10 | $0.81 | $0.36 | $0.72 | $0.79 | $0.83 | $0.78 | $0.66 | $0.52 |
| Avg Forecast | $0.10 | $0.27 | $0.33 | $0.20 | $0.23 | $0.20 | $0.17 | $0.05 | $-0.03 | $0.64 | $0.53 | $0.30 | $0.44 | $0.37 | $0.79 | $0.72 | $0.95 | $0.86 | $1.05 | $0.73 | $1.19 | $1.00 | $0.60 | $0.25 | $0.72 | $0.76 | $0.83 | $0.71 | $0.74 | $0.49 |
| High Forecast | $0.10 | $0.28 | $0.34 | $0.20 | $0.23 | $0.20 | $0.17 | $0.05 | $-0.02 | $0.72 | $0.55 | $0.31 | $0.46 | $0.37 | $0.79 | $0.72 | $0.95 | $0.86 | $1.07 | $0.73 | $1.19 | $1.00 | $0.60 | $0.25 | $0.72 | $0.76 | $0.83 | $0.71 | $0.89 | $0.59 |
| Low Forecast | $0.10 | $0.26 | $0.32 | $0.19 | $0.22 | $0.19 | $0.17 | $0.05 | $-0.03 | $0.59 | $0.52 | $0.29 | $0.43 | $0.37 | $0.79 | $0.72 | $0.95 | $0.86 | $1.03 | $0.73 | $1.19 | $1.00 | $0.60 | $0.25 | $0.72 | $0.76 | $0.83 | $0.71 | $0.59 | $0.39 |
| Surprise % | - | - | - | - | - | - | - | - | -6.00% | -1.15% | 1.01% | 0.77% | 2.62% | -1.38% | 0.87% | 1.07% | -0.20% | 1.15% | 1.13% | 1.29% | 1.20% | 1.10% | 1.34% | 1.45% | 1.00% | 1.04% | 1.00% | 1.10% | 0.89% | 1.06% |
According to 1 Wall Street analysts, Nu Skin Enterprises's projected average Quarter EPS for Mar 24 is $0.05, with a low estimate of $0.05 and a high estimate of $0.05. This represents a -66.91% decrease compared to NUS previous annual EPS of $0.15 (Dec 23).
Nu Skin Enterprises Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| HLF | Herbalife Nutrition | $7.12 | $18.83 | 164.47% | Buy |
| NUS | Nu Skin Enterprises | $7.32 | $11.00 | 50.27% | Strong Buy |
| PII | Polaris | $60.79 | $78.80 | 29.63% | Hold |
| IPAR | Inter Parfums | $133.41 | $163.50 | 22.55% | Buy |
| USNA | USANA Health Sciences | $36.28 | $35.00 | -3.53% | |
| FLO | Flowers Foods | $20.92 | $20.00 | -4.40% | Hold |